Cuccurullo V - Search Results

1

Unespected dectection of unruptured brain arteriovenous malformation with ¹⁸F-DOPA PET/MR.

Cuccurullo V, Arcuri PP, Cicone F, Barberio P, Manti F, Cascini GL. Cuccurullo V, et al. Hell J Nucl Med. 2022 May-Aug;25(2):213-215. doi: 10.1967/s002449912482. Epub 2022 Aug 3. Hell J Nucl Med. 2022. PMID: 35913869 Free article.

2

[Immunological imaging using tagged octreotide].

Cascini GL, Cuccurullo V, Rambaldi PF, Mansi L. Cascini GL, et al. Among authors: cuccurullo v. Minerva Endocrinol. 2001 Sep;26(3):129-33. Minerva Endocrinol. 2001. PMID: 11753235 Review. Italian.

3

[Role of somatostatin analogs in the treatment of neuroendocrine tumours].

Cuccurullo V, Cascini GL, Rambaldi PF, Mansi L. Cuccurullo V, et al. Minerva Endocrinol. 2001 Sep;26(3):135-43. Minerva Endocrinol. 2001. PMID: 11753236 Review. Italian.

4

The present and future role of (111)In pentetreotide in the PET era.

Rambaldi PF, Cuccurullo V, Briganti V, Mansi L. Rambaldi PF, et al. Among authors: cuccurullo v. Q J Nucl Med Mol Imaging. 2005 Sep;49(3):225-35. Q J Nucl Med Mol Imaging. 2005. PMID: 16172568 Free article. Review.

5

The non tumour uptake of (111)In-octreotide creates new clinical indications in benign diseases, but also in oncology.

Cascini GL, Cuccurullo V, Mansi L. Cascini GL, et al. Among authors: cuccurullo v. Q J Nucl Med Mol Imaging. 2010 Feb;54(1):24-36. Q J Nucl Med Mol Imaging. 2010. PMID: 20168284 Free article. Review.

6

Our experience in thymic hyperplasia using 67Ga-citrate, 111In-pentetreotide and 201Tl-chloride.

Rambaldi PF, Cuccurullo V, Cascini GL, Mansi L. Rambaldi PF, et al. Among authors: cuccurullo v. Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1616. doi: 10.1007/s00259-010-1487-0. Epub 2010 May 27. Eur J Nucl Med Mol Imaging. 2010. PMID: 20505931 No abstract available.

7

Nuclear medicine in multiple myeloma -- more than diagnosis.

Cascini GL, Cuccurullo V, Tamburrini O, Mansi L, Rotondo A. Cascini GL, et al. Among authors: cuccurullo v. Nucl Med Rev Cent East Eur. 2010;13(1):32-8. Nucl Med Rev Cent East Eur. 2010. PMID: 21154314 Review.

8

Less frequent requests for In-111 pentreotide and its brothers of endocrinological interest.

Cuccurullo V, Cascini GL, Tamburrini O, Mansi L, Rotondo A. Cuccurullo V, et al. Minerva Endocrinol. 2011 Mar;36(1):41-52. Minerva Endocrinol. 2011. PMID: 21460786 Review.

9

Pathophysiological premises to radiotracers for bone metastases.

Cuccurullo V, Cascini G, Rossi A, Tamburrini O, Rotondo A, Mansi L. Cuccurullo V, et al. Q J Nucl Med Mol Imaging. 2011 Aug;55(4):353-73. Q J Nucl Med Mol Imaging. 2011. PMID: 21738112 Review.

10

Questions and answers: what can be said by diagnostic imaging in neuroendocrine tumors?

Cuccurullo V, Faggiano A, Scialpi M, Cascini GL, Piunno A, Catalano O, Colao A, Mansi L. Cuccurullo V, et al. Minerva Endocrinol. 2012 Dec;37(4):367-77. Minerva Endocrinol. 2012. PMID: 23235192 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters